DUL:ETR
Alnylam Pharmaceuticals, Inc.
၁၉၉.၇၅ €
arrow_downward
-၁.၂၁%(-၂.၄၅) 1D
အောက် ၁၅, GMT+၂ ၀၉:၀၄:၃၂ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DUL...
Open
၁၉၉.၇၅ €
High
၁၉၉.၇၅ €
Low
၁၉၉.၇၅ €
Mkt. cap
ဋေ ၃.၀၀ ထ
Avg. vol.
၃၈.၀၀
Volume
၀.၀၀
52-wk high
၄၁၇.၄၀ €
52-wk low
၁၇၇.၁၀ €
No. of employees
၂ ထောင်
Open
၁၉၉.၇၅ €
High
၁၉၉.၇၅ €
Low
၁၉၉.၇၅ €
Mkt. cap
ဋေ ၃.၀၀ ထ
Avg. vol.
၃၈.၀၀
Volume
၀.၀၀
52-wk high
၄၁၇.၄၀ €
52-wk low
၁၇၇.၁၀ €
No. of employees
၂ ထောင်
News stories
From web sources and news partners
BioSpace
·
ပြီးခဲ့သည့် ၁ ရက်
Alnylam bulls and bears fight it out after business-shaking guidance cut
The Globe and Mail
·
ပြီးခဲ့သည့် ၂ ပတ်
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.